I agree with the thought lines, but there is an international licence issue still unresolved. Why?
GPP are aware or Mr King wiuldnt have mentioned it in the announcement comments. Oversight?
I believe GPP need to explaib the relationship in more detail, along with the intricacies of the licence agreement regarding alternate products to biostimulant.
That line regarding commercial objectives l think has destabilised the SP.
What is the reality?
I would like thank the contribution of all HC posters, its a good discussion. Thanks all.
Ann: Successful OHD Cereal Crop Trials, page-680
Add GNM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.855M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 674997 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 100001 | 2 |
View Market Depth
| Last trade - 16.12pm 18/11/2024 (20 minute delay) ? |
| GNM (ASX) Chart |
Day chart unavailable